Sympathectomy, endoscopic transthoracic

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

ETS

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Operative dissection of individual ganglia of the sympathetic nervous system for the treatment of hyperhidrosis axillaris, erythrophobia, hyperhidrosis pedum et manuum and endangiitis obliterans.

General definitionThis section has been translated automatically.

  • Minimally invasive procedure through several smaller incisions in the armpit.
  • The operation is performed under general anaesthesia.
  • High recurrence rate postoperatively in approx. 65% of the treated patients.
  • Short hospital stay: in general, patients can leave the hospital after a few days.

Complication(s)This section has been translated automatically.

  • Horner's syndrome (after injury of the upper ganglion)
  • Recurrent paresis (paralysis of the vocal chords due to damage of the recurrent nerve to the vocal fold with hoarseness)
  • Pleural effusion.

Note(s)This section has been translated automatically.

Regular occurrence of compensatory sweating (e.g. increased sweating at the integument while reducing sweating of the arms).

LiteratureThis section has been translated automatically.

  1. Lowe NJ et al (2007) Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety. J Am Acad Dermatol 56: 604-611

Authors

Last updated on: 29.10.2020